Merck
$MRK · NYSE · HEALTHCARE · 2 stories in 30 daysThe wire on $MRK
newest first · duplicate source posts collapse into one event · direct subject stories onlyUpgrades and downgrades: AVAL, ENTG, IEX, ISRG, JOYY, MRK, OKTA up; APGE, ATAI, CRDF, GAP, LEGN, NVO, ONON, TME down
Upgrades and downgrades: AVAL, ENTG, IEX, ISRG, JOYY, MRK, OKTA up; APGE, ATAI, CRDF, GAP, LEGN, NVO, ONON, TME down.
neutral 50 · impact 30Merck and Moderna report first positive Phase 3 result for personalized cancer vaccine
Merck and Moderna announced positive Phase 3 results for intismeran autogene, an mRNA personalized cancer vaccine, combined with Keytruda in melanoma. The trial met recurrence-free and distant metastasis-free survival endpoints. Full data to be presented at a medical meeting; regulatory submissions to begin.
bullish 80 · impact 85News tells you what happened. The tape shows whether it mattered.
Explore the exact intelligence modules available on every supported company page.
BORSAPLUSUnlock the intelligence behind the signal.
Create free account · 3 views/day